Dr Reddys Laboratories Ltd (NSE): Share Price and Fundamentals

The current share price of Dr Reddy's Laboratories is ₹1,246.50, with a market capitalization of ₹1,04,013.74. The stock is currently trading at the P/E ratio of 18.31x and it has a Debt/Equity ratio of 0.14x.

In Jun 2025, the company announced sales of ₹8,572.00 and net profit of ₹1,410.00. TTM ROE stands at 16.86% with promoter holding of 26.64%.

Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).